uniQure (QURE) Non-Current Debt (2015 - 2026)
uniQure (QURE) posted quarterly Non-Current Debt of $50.1 million for Q2 2026, down 3.27% year-over-year from $51.8 million in Q2 2025, and little changed quarter-over-quarter from $49.9 million in Q1 2026.
uniQure (QURE) Non-Current Debt (2015 - 2026) Analysis & Trends
uniQure's Non-Current Debt history runs 12 years deep, the most recent figure standing at $50.1 million for Q2 2026.
- In Q2 2026, Non-Current Debt fell 3.27% year-over-year to $50.1 million; the TTM figure through Jun 2026 stood at $50.1 million (down 3.27% YoY), while the FY2025 annual figure was $49.7 million, down 3.17% from the prior year.
- Non-Current Debt for Q2 2026 stood at $50.1 million, roughly flat from $49.9 million in the prior quarter.
- The five-year high for Non-Current Debt was $103.3 million in Q1 2023, with the low at $49.7 million in Q4 2025.
- The 5-year median for Non-Current Debt is $101.3 million (2022), against an average of $79.3 million.
- The sharpest annual moves came in 2022 and 2024: Non-Current Debt jumped 43.95% in 2022, then sank 49.61% in 2024.
- uniQure's Non-Current Debt stood at $102.8 million in 2022, then dropped by 1.01% to $101.7 million in 2023, then sank by 49.56% to $51.3 million in 2024, then fell by 3.17% to $49.7 million in 2025, then climbed by 0.9% to $50.1 million in 2026.
- Business Quant data shows QURE's Non-Current Debt at $50.1 million in Q2 2026, $49.9 million in Q1 2026, and $49.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 882.16 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 8.96 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | uniQure | 3.37 Bn | 3.37 Bn | 5.49 Mn | 50.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 50.15 Mn |
| Mar 31, 2026 | 49.94 Mn |
| Dec 31, 2025 | 49.70 Mn |
| Sep 30, 2025 | 51.88 Mn |
| Jun 30, 2025 | 51.84 Mn |
| Mar 31, 2025 | 51.59 Mn |
| Dec 31, 2024 | 51.32 Mn |
| Sep 30, 2024 | 51.11 Mn |
| Jun 30, 2024 | 102.51 Mn |
| Mar 31, 2024 | 102.12 Mn |
| Dec 31, 2023 | 101.75 Mn |
| Sep 30, 2023 | 101.43 Mn |
| Jun 30, 2023 | 101.11 Mn |
| Mar 31, 2023 | 103.25 Mn |
| Dec 31, 2022 | 102.79 Mn |
| Sep 30, 2022 | 102.39 Mn |
| Jun 30, 2022 | 101.89 Mn |
| Mar 31, 2022 | 101.42 Mn |
| Dec 31, 2021 | 100.96 Mn |
| Sep 30, 2021 | 71.49 Mn |